Koyfin Home > Directory > Health Care > Aquestive Therapeutics Inc > Gross Profit

Aquestive Therapeutics Inc Gross Profit Chart (AQST)

Aquestive Therapeutics Inc annual/quarterly Gross Profit from 2006 to 2018. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Aquestive Therapeutics Inc Gross Profit for the quarter ending December 12, 2018 was $12m a -47.67% decrease of -6m year over year
  • Aquestive Therapeutics Inc Gross Profit for the last 12 months ending December 12, 2018 was $46m a -13.30% decrease of -6m year over year
  • Aquestive Therapeutics Inc Annual Gross Profit for 2018 was $46m a -1.41% decrease of -1m from 2017
  • Aquestive Therapeutics Inc Annual Gross Profit for 2017 was $47m a 24.82% increase of 12m from 2016
  • Aquestive Therapeutics Inc Annual Gross Profit for 2016 was $35m a 96.92% increase of 34m from 2015
Other Income Statement Metrics:
  • Aquestive Therapeutics Inc EBITDA for the quarter ending December 12, 2018 was $-12m a 154.38% decrease of -18m year over year
  • Aquestive Therapeutics Inc Net Income for the quarter ending December 12, 2018 was $-14m a 129.40% decrease of -18m year over year
  • Aquestive Therapeutics Inc Total Revenue for the quarter ending December 12, 2018 was $17m a -39.15% decrease of -7m year over year
View Chart On Koyfin

Quarterly AQST Gross Profit Data

12/2018$12m
09/2018$8m
06/2018$9m
03/2018$18m
12/2017$7m
09/2017$22m
06/2017$6m
03/2017$12m
06/2007$1m
03/2007$0m

Annual AQST Gross Profit Data

2018$46m
2017$47m
2016$35m
2006$1m
2005$1m
2004$1m